G. Martin Benson - Concepedia

Author

G. Martin Benson

Also Known As

Benson, G.M., G Benson, G Martin Benson, G. M. Benson, G. MARTIN BENSON, G. Martin Benson, G.M Benson, G.M. Benson, G.Martin Benson, Gregory Benson

Publications

1.7K

Citations

H-Index

Concepts

All Affiliations

GlaxoSmithKline (United Kingdom)New Frontier Roche (Switzerland)Molecular Discovery (United Kingdom)University of North Carolina at Chapel Hill

About

G. Martin Benson is an author at GlaxoSmithKline (United Kingdom) specializing in medicine, physiology, and health sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	19	940
2	Health Sciences	10	10	490
3	Natural Sciences	3	3	138
4	Education	2	2	66
5	Public Health	2	2	234

G. Martin Benson

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
Transgenic human C-reactive protein is not proatherogenic in apolipoprotein E-deficient mice Gideon M. Hirschfield, J. Ruth Gallimore, Melvyn Kahan, Proceedings of the National Academy of Sciences	2005	192
Complement C1q Reduces Early Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient Mice Vinay K. Bhatia, Sheng Yun, Viola Leung, American Journal Of Pathology InflammationMetabolic SyndromeComplement SystemVascular DiseaseCardiovascular Disease	2007	161
A thyromimetic that decreases plasma cholesterol levels without increasing cardiac activity A. H. Underwood, J. C. EMMETT, David A. Ellis, Nature Cardiovascular DiseasePhysiologyCholesterol LevelsHyperlipidemiaMedicine	1986	130
Cholesterol lowering and bile acid excretion in the hamster with cholestyramine treatment Keith E. Suckling, G. Martin Benson, Brian Bond, Atherosclerosis Animal PhysiologyNutritionOxysterolCholestyramine TreatmentBiliary Tract	1991	121
Quantitative Assessment of Aortic Atherosclerosis in APOE*3 Leiden Transgenic Mice and Its Relationship to Serum Cholesterol Exposure Pieter H.E. Groot, Bart J.M. van Vlijmen, G. Martin Benson, Arteriosclerosis Thrombosis and Vascular Biology NutritionVascular DiseaseImmunologyGenetic EpidemiologyHyperlipidemia	1996	113
Optimization of a novel class of benzimidazole-based farnesoid X receptor (FXR) agonists to improve physicochemical and ADME properties Hans Richter, G. Martin Benson, Konrad Bleicher, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryBiochemistryMedicineNatural SciencesAdme Properties	2011	76
Transplantation of Monocyte CC-Chemokine Receptor 2–Deficient Bone Marrow Into ApoE3–Leiden Mice Inhibits Atherogenesis Jian Guo, Miranda Van Eck, Jaap Twisk, Arteriosclerosis Thrombosis and Vascular Biology	2003	69
Repeated Three-Dimensional Magnetic Resonance Imaging of Atherosclerosis Development in Innominate Arteries of Low-Density Lipoprotein Receptor-Knockout Mice Paul Hockings, Toby J Roberts, Graham J. Galloway, Circulation	2002	57
Discovery of novel and orally active FXR agonists for the potential treatment of dyslipidemia & diabetes Hans Richter, G. Martin Benson, Denise Blum, Bioorganic & Medicinal Chemistry Letters Molecular PharmacologyActive Fxr AgonistsMedicineDiabetesPharmacological Agent	2010	56
Impact of Parental Substance Use on Adolescents: A Test of a Mediational Model Thomas A. Wills, Daniel Schreibman, G. Martin Benson, Journal of Pediatric Psychology Substance AbuseBehavioral SciencesSubstance UsePsychiatryMediational Model	1994	56

Page 1